BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16989616)

  • 1. Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression.
    Bedoya VI; Boasso A; Hardy AW; Rybak S; Shearer GM; Rugeles MT
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):897-907. PubMed ID: 16989616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition.
    Rugeles MT; Trubey CM; Bedoya VI; Pinto LA; Oppenheim JJ; Rybak SM; Shearer GM
    AIDS; 2003 Mar; 17(4):481-6. PubMed ID: 12598767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation.
    Yang D; Chen Q; Rosenberg HF; Rybak SM; Newton DL; Wang ZY; Fu Q; Tchernev VT; Wang M; Schweitzer B; Kingsmore SF; Patel DD; Oppenheim JJ; Howard OM
    J Immunol; 2004 Nov; 173(10):6134-42. PubMed ID: 15528350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity.
    Sikriwal D; Seth D; Parveen S; Malik A; Broor S; Batra JK
    J Cell Biochem; 2012 Oct; 113(10):3104-12. PubMed ID: 22581709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNase inhibition of human immunodeficiency virus infection of H9 cells.
    Youle RJ; Wu YN; Mikulski SM; Shogen K; Hamilton RS; Newton D; D'Alessio G; Gravell M
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6012-6. PubMed ID: 8016107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal-maternal HLA-A and -B discordance is associated with placental RNase expression and anti-HIV-1 activity.
    Bedoya VI; Jaimes FA; Delgado JC; Rugeles C; Usuga X; Zapata W; Castaño ME; Boasso A; Shearer G; Rugeles MT
    Curr HIV Res; 2008 Jun; 6(4):380-7. PubMed ID: 18691036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).
    Dimitrova DI; Reichenbach NL; Yang X; Pfleiderer W; Charubala R; Gaughan JP; Suh B; Henderson EE; Suhadolnik RJ; Rogers TJ
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):123-34. PubMed ID: 17263642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus.
    Domachowske JB; Bonville CA; Dyer KD; Rosenberg HF
    Nucleic Acids Res; 1998 Dec; 26(23):5327-32. PubMed ID: 9826755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells.
    Yang D; Rosenberg HF; Chen Q; Dyer KD; Kurosaka K; Oppenheim JJ
    Blood; 2003 Nov; 102(9):3396-403. PubMed ID: 12855582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector.
    Cara A; Rybak SM; Newton DL; Crowley R; Rottschafer SE; Reitz MS; Gusella GL
    Gene Ther; 1998 Jan; 5(1):65-75. PubMed ID: 9536266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction.
    Suzuki M; Saxena SK; Boix E; Prill RJ; Vasandani VM; Ladner JE; Sung C; Youle RJ
    Nat Biotechnol; 1999 Mar; 17(3):265-70. PubMed ID: 10096294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.
    Domachowske JB; Dyer KD; Adams AG; Leto TL; Rosenberg HF
    Nucleic Acids Res; 1998 Jul; 26(14):3358-63. PubMed ID: 9649619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
    Slifman NR; Loegering DA; McKean DJ; Gleich GJ
    J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
    Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
    Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribotoxin restrictocin manifests anti-HIV-1 activity through its specific ribonuclease activity.
    Yadav SK; Batra JK
    Int J Biol Macromol; 2015 May; 76():58-62. PubMed ID: 25709025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense.
    Rosenberg HF
    Int J Mol Sci; 2015 Jul; 16(7):15442-55. PubMed ID: 26184157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of human eosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human nonsecretory ribonucleases.
    Hamann KJ; Barker RL; Loegering DA; Pease LR; Gleich GJ
    Gene; 1989 Nov; 83(1):161-7. PubMed ID: 2591744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen-stimulated anti-HIV activity.
    Pinto LA; Sharpe S; Cohen DI; Shearer GM
    Blood; 1998 Nov; 92(9):3346-54. PubMed ID: 9787172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.